Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC3282498695;98696;98697 chr2:178539595;178539594;178539593chr2:179404322;179404321;179404320
N2AB3118393772;93773;93774 chr2:178539595;178539594;178539593chr2:179404322;179404321;179404320
N2A3025690991;90992;90993 chr2:178539595;178539594;178539593chr2:179404322;179404321;179404320
N2B2375971500;71501;71502 chr2:178539595;178539594;178539593chr2:179404322;179404321;179404320
Novex-12388471875;71876;71877 chr2:178539595;178539594;178539593chr2:179404322;179404321;179404320
Novex-22395172076;72077;72078 chr2:178539595;178539594;178539593chr2:179404322;179404321;179404320
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: G
  • RefSeq wild type transcript codon: GGT
  • RefSeq wild type template codon: CCA
  • Domain: Fn3-127
  • Domain position: 30
  • Structural Position: 31
  • Q(SASA): 0.2407
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
G/D None None 1.0 N 0.836 0.511 0.443797312901 gnomAD-4.0.0 6.84179E-07 None None None None I None 0 0 None 0 0 None 0 0 0 1.15931E-05 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
G/A 0.9282 likely_pathogenic 0.9102 pathogenic -0.287 Destabilizing 1.0 D 0.725 prob.delet. N 0.514633824 None None I
G/C 0.9787 likely_pathogenic 0.973 pathogenic -0.735 Destabilizing 1.0 D 0.784 deleterious D 0.542399317 None None I
G/D 0.9931 likely_pathogenic 0.9917 pathogenic -0.674 Destabilizing 1.0 D 0.836 deleterious N 0.513619866 None None I
G/E 0.9957 likely_pathogenic 0.9949 pathogenic -0.844 Destabilizing 1.0 D 0.844 deleterious None None None None I
G/F 0.998 likely_pathogenic 0.9976 pathogenic -1.116 Destabilizing 1.0 D 0.779 deleterious None None None None I
G/H 0.9972 likely_pathogenic 0.9966 pathogenic -0.623 Destabilizing 1.0 D 0.804 deleterious None None None None I
G/I 0.998 likely_pathogenic 0.9975 pathogenic -0.411 Destabilizing 1.0 D 0.784 deleterious None None None None I
G/K 0.9975 likely_pathogenic 0.9969 pathogenic -0.722 Destabilizing 1.0 D 0.845 deleterious None None None None I
G/L 0.9967 likely_pathogenic 0.9961 pathogenic -0.411 Destabilizing 1.0 D 0.797 deleterious None None None None I
G/M 0.9984 likely_pathogenic 0.998 pathogenic -0.286 Destabilizing 1.0 D 0.787 deleterious None None None None I
G/N 0.9938 likely_pathogenic 0.9922 pathogenic -0.316 Destabilizing 1.0 D 0.804 deleterious None None None None I
G/P 0.9995 likely_pathogenic 0.9993 pathogenic -0.336 Destabilizing 1.0 D 0.823 deleterious None None None None I
G/Q 0.9956 likely_pathogenic 0.9947 pathogenic -0.647 Destabilizing 1.0 D 0.822 deleterious None None None None I
G/R 0.9886 likely_pathogenic 0.986 pathogenic -0.274 Destabilizing 1.0 D 0.827 deleterious N 0.49602259 None None I
G/S 0.9195 likely_pathogenic 0.8905 pathogenic -0.449 Destabilizing 1.0 D 0.803 deleterious N 0.503655912 None None I
G/T 0.992 likely_pathogenic 0.9896 pathogenic -0.555 Destabilizing 1.0 D 0.842 deleterious None None None None I
G/V 0.9953 likely_pathogenic 0.9941 pathogenic -0.336 Destabilizing 1.0 D 0.802 deleterious N 0.510051921 None None I
G/W 0.9952 likely_pathogenic 0.9946 pathogenic -1.273 Destabilizing 1.0 D 0.805 deleterious None None None None I
G/Y 0.9972 likely_pathogenic 0.9966 pathogenic -0.903 Destabilizing 1.0 D 0.773 deleterious None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.